GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

TableEdit

Jump to: navigation, search

PMID:18840707

You don't have sufficient rights on this wiki to edit tables. Perhaps you need to log in. Changes you make in the Table editor will not be saved back to the wiki

See Help for Help on this wiki. See the documentation for how to use the table editor

Citation

Park, IK, Giovenzana, C, Hughes, TL, Yu, J, Trotta, R and Caligiuri, MA (2009) The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development. Blood 113:2470-7

Abstract

Interleukin-15 (IL-15) is essential for natural killer (NK) cell differentiation. In this study, we assessed whether the receptor tyrosine kinase Axl and its ligand, Gas6, are involved in IL-15-mediated human NK differentiation from CD34(+) hematopoietic progenitor cells (HPCs). Blocking the Axl-Gas6 interaction with a soluble Axl fusion protein (Axl-Fc) or the vitamin K inhibitor warfarin significantly diminished the absolute number and percentage of CD3(-)CD56(+) NK cells derived from human CD34(+) HPCs cultured in the presence of IL-15, probably resulting in part from reduced phosphorylation of STAT5. In addition, CD3(-)CD56(+) NK cells derived from culture of CD34(+) HPCs with IL-15 and Axl-Fc had a significantly diminished capacity to express interferon-gamma or its master regulator, T-BET. Culture of CD34(+) HPCs in the presence of c-Kit ligand and Axl-Fc resulted in a significant decrease in the frequency of NK precursor cells responding to IL-15, probably the result of reduced c-Kit phosphorylation. Collectively, our data suggest that the Axl/Gas6 pathway contributes to normal human NK-cell development, at least in part via its regulatory effects on both the IL-15 and c-Kit signaling pathways in CD34(+) HPCs, and to functional NK-cell maturation via an effect on the master regulatory transcription factor T-BET.

Links

PubMed PMC2656272 Online version:10.1182/blood-2008-05-157073

Keywords

Antigens, CD34/metabolism; Antigens, CD34/physiology; Cell Differentiation/drug effects; Cell Differentiation/genetics; Cells, Cultured; Cytokines/pharmacology; Cytokines/physiology; Hematopoietic Stem Cells/drug effects; Hematopoietic Stem Cells/metabolism; Hematopoietic Stem Cells/physiology; Humans; Intercellular Signaling Peptides and Proteins/genetics; Intercellular Signaling Peptides and Proteins/physiology; Interleukin-15/pharmacology; Interleukin-15/physiology; K562 Cells; Killer Cells, Natural/drug effects; Killer Cells, Natural/metabolism; Killer Cells, Natural/physiology; Oncogene Proteins/genetics; Oncogene Proteins/physiology; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-kit/metabolism; Proto-Oncogene Proteins c-kit/physiology; Receptor Protein-Tyrosine Kinases/genetics; Receptor Protein-Tyrosine Kinases/physiology; Signal Transduction/drug effects; Signal Transduction/genetics; Signal Transduction/physiology; T-Box Domain Proteins/physiology

public



Cancel